Target Price | $13.73 |
Price | $9.22 |
Potential |
48.86%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Brainsway Ltd Sponsored ADR 2025 .
The average Brainsway Ltd Sponsored ADR target price is $13.73.
This is
48.86%
register free of charge
$16.00
73.54%
register free of charge
$12.50
35.57%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Brainsway Ltd Sponsored ADR to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Brainsway Ltd Sponsored ADR stock has an average upside potential 2025 of
48.86%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 31.79 | 40.45 |
16.96% | 27.24% | |
EBITDA Margin | -11.29% | 15.90% |
70.26% | 240.80% |
4 Analysts have issued a sales forecast Brainsway Ltd Sponsored ADR 2024 . The average Brainsway Ltd Sponsored ADR sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Brainsway Ltd Sponsored ADR 2024 . The average Brainsway Ltd Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
EV/Sales | 3.05 |
Based on analysts' sales estimates for 2024, the Brainsway Ltd Sponsored ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Brainsway Ltd Sponsored ADR...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.